184 related articles for article (PubMed ID: 32588652)
1. Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study.
Rustichelli C; Bellei E; Bergamini S; Monari E; Baraldi C; Castro FL; Tomasi A; Ferrari A
Cephalalgia; 2020 Oct; 40(12):1355-1362. PubMed ID: 32588652
[TBL] [Abstract][Full Text] [Related]
2. Migraine and reporoductive hormones throughout the menstrual cycle.
Epstein MT; Hockaday JM; Hockaday TD
Lancet; 1975 Mar; 1(7906):543-8. PubMed ID: 47017
[TBL] [Abstract][Full Text] [Related]
3. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
[TBL] [Abstract][Full Text] [Related]
4. The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs.
Beckham JC; Krug LM; Penzien DB; Johnson CA; Mosley TH; Meeks GR; Pbert LA; Prather RC
Headache; 1992 Jun; 32(6):292-7. PubMed ID: 1399550
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.
Genazzani AR; Petraglia F; Bernardi F; Casarosa E; Salvestroni C; Tonetti A; Nappi RE; Luisi S; Palumbo M; Purdy RH; Luisi M
J Clin Endocrinol Metab; 1998 Jun; 83(6):2099-103. PubMed ID: 9626145
[TBL] [Abstract][Full Text] [Related]
6. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
Slopien R; Pluchino N; Warenik-Szymankiewicz A; Sajdak S; Luisi M; Drakopoulos P; Genazzani AR
Gynecol Endocrinol; 2018 Feb; 34(2):144-147. PubMed ID: 28857628
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study.
Rustichelli C; Bellei E; Bergamini S; Monari E; Lo Castro F; Baraldi C; Tomasi A; Ferrari A
J Headache Pain; 2021 Mar; 22(1):13. PubMed ID: 33757421
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of menstrually related and non-menstrual migraine.
Güven B; Güven H; Çomoğlu S
Acta Neurol Belg; 2017 Sep; 117(3):671-676. PubMed ID: 28560689
[TBL] [Abstract][Full Text] [Related]
9. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone.
Andréen L; Spigset O; Andersson A; Nyberg S; Bäckström T
Maturitas; 2006 Jun; 54(3):238-44. PubMed ID: 16406399
[TBL] [Abstract][Full Text] [Related]
11. High levels of serum allopregnanolone in women with premature ovarian failure.
Bernardi F; Hartmann B; Casarosa E; Luisi S; Stomati M; Fadalti M; Florio P; Santuz M; Luisi M; Petraglia F; Genazzani AR
Gynecol Endocrinol; 1998 Oct; 12(5):339-45. PubMed ID: 9859027
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of androgens and migraine in postmenopausal women.
Mattsson P
Clin Sci (Lond); 2002 Nov; 103(5):487-91. PubMed ID: 12401121
[TBL] [Abstract][Full Text] [Related]
13. Population-Based Characterization of Menstrual Migraine and Proposed Diagnostic Criteria.
Chalmer MA; Kogelman LJA; Ullum H; Sørensen E; Didriksen M; Mikkelsen S; Dinh KM; Brodersen T; Nielsen KR; Bruun MT; Banasik K; Brunak S; Erikstrup C; Pedersen OB; Ostrowski SR; Olesen J; Hansen TF
JAMA Netw Open; 2023 May; 6(5):e2313235. PubMed ID: 37184838
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and biology of menstrual migraine.
Martin VT; Lipton RB
Headache; 2008; 48 Suppl 3():S124-30. PubMed ID: 19076658
[TBL] [Abstract][Full Text] [Related]
15. Burden of migraine related to menses: results from the AMPP study.
Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
[TBL] [Abstract][Full Text] [Related]
16. Proteomic serum profile in menstrual-related and post menopause migraine.
Bellei E; Rustichelli C; Bergamini S; Monari E; Baraldi C; Lo Castro F; Tomasi A; Ferrari A
J Pharm Biomed Anal; 2020 May; 184():113165. PubMed ID: 32113117
[TBL] [Abstract][Full Text] [Related]
17. Migraine and cluster headache show impaired neurosteroids patterns.
Koverech A; Cicione C; Lionetto L; Maestri M; Passariello F; Sabbatini E; Capi M; De Marco CM; Guglielmetti M; Negro A; Di Menna L; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2019 May; 20(1):61. PubMed ID: 31132992
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University.
Dzoljic E; Sipetic S; Vlajinac H; Marinkovic J; Brzakovic B; Pokrajac M; Kostic V
Headache; 2002 Mar; 42(3):185-93. PubMed ID: 11903541
[TBL] [Abstract][Full Text] [Related]
20. Differences in topological properties of functional brain networks between menstrually-related and non-menstrual migraine without aura.
Zhang Y; Xu T; Wang Z; Li D; Du J; Wen Y; Zhao Y; Liao H; Liang F; Zhao L
Brain Imaging Behav; 2021 Jun; 15(3):1450-1459. PubMed ID: 32705466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
